M Ayres
Overview
Explore the profile of M Ayres including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
332
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thomas C, Ayres M, Pye K, Yassin D, Howell S, Alderson S
Perioper Med (Lond)
. 2023 Jul;
12(1):34.
PMID: 37430326
Opioids are effective analgesics but can cause harm. Opioid stewardship is key to ensuring that opioids are used effectively and safely. There is no agreed set of quality indicators relating...
2.
Killington M, Mackintosh S, Ayres M
Brain Inj
. 2010 Jun;
24(7-8):970-7.
PMID: 20545451
Primary Objective: To investigate if an isokinetic strength training programme for leg muscles lead to personally meaningful changes in adults with an acquired brain injury (ABI). Research Design: A qualitative...
3.
Van Zwieten L, Ahmad N, Marolt R, Ayres M, Morris S
J Environ Sci Health B
. 2001 Oct;
36(5):501-16.
PMID: 11599716
Soil taken from a former cattle tick dip site in NSW Australia, was remediated with a chemical leaching technology. The pre- and post-remediated soil (20g) was dispersed in water (100mL)...
4.
Pimm S, Ayres M, Balmford A, BRANCH G, Brandon K, Brooks T, et al.
Science
. 2001 Sep;
293(5538):2207-8.
PMID: 11567124
No abstract available.
5.
Gandhi V, Ayres M, Halgren R, Krett N, Newman R, Rosen S
Cancer Res
. 2001 Jul;
61(14):5474-9.
PMID: 11454694
Previous work with 8-chloro-cAMP (8-Cl-cAMP) has raised questions as to whether it works as a cAMP analogue or as a nucleoside analogue after its conversion to 8-chloro-adenosine (8-Cl-Ado). Although degradation...
6.
Gandhi V, Plunkett W, Weller S, Du M, Ayres M, Rodriguez Jr C, et al.
J Clin Oncol
. 2001 Apr;
19(8):2142-52.
PMID: 11304766
Purpose: A pilot protocol was designed to evaluate the efficacy of fludarabine with nelarabine (the prodrug of arabinosylguanine [ara-G]) in patients with hematologic malignancies. The cellular pharmacokinetics was investigated to...
7.
Taylor G, Gokhale D, Crowther D, Woll P, Harris M, Ryder D, et al.
Br J Cancer
. 1999 Jul;
80(9):1405-11.
PMID: 10424743
It has been suggested in a number of studies that susceptibility to adult Hodgkin's disease (HD) is influenced by the HLA class II region, and specifically by alleles at the...
8.
Esente P, KAPLAN A, FORD J, Martin J, Ayres M, Kosinski E, et al.
Catheter Cardiovasc Interv
. 1999 Jun;
47(2):237-42.
PMID: 10376513
The feasibility and safety of local heparin delivery during acute infarct angioplasty was evaluated in a prospective, multicenter, 120-patient series. Angioplasty was performed using standard techniques, after which heparin (4,000...
9.
Gandhi V, Plunkett W, Rodriguez Jr C, Nowak B, Du M, Ayres M, et al.
J Clin Oncol
. 1998 Nov;
16(11):3607-15.
PMID: 9817282
Purpose: In vitro investigations with arabinosylguanine (ara-G) demonstrated potent cytotoxicity to T-lymphoblastoid cell lines. The goals of the present study were to evaluate GW506U78, a prodrug of ara-G, against human...
10.
Arkwright P, Makin G, Will A, Ayres M, Gokhale D, Fergusson W, et al.
Arch Dis Child
. 1998 Oct;
79(1):52-5.
PMID: 9771253
X linked lymphoproliferative disease (XLP; Duncan's disease) is a rare disorder affecting boys and characterised by a defective immune response to Epstein-Barr virus caused by a mutation in a gene...